Follow
Ketan Patil
Ketan Patil
St. John's University, NY (Past: Regeneron Pharmaceuticals, NY)
Verified email at stjohns.edu
Title
Cited by
Cited by
Year
Cellular proteostasis in neurodegeneration
A Kurtishi, B Rosen, KS Patil, GW Alves, SG Møller
Molecular neurobiology 56, 3676-3689, 2019
1772019
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases
I Basak, KS Patil, G Alves, JP Larsen, SG Møller
Cellular and Molecular Life Sciences 73, 811-827, 2016
1162016
Parkinson's disease and age: the obvious but largely unexplored link
R Abdullah, I Basak, KS Patil, G Alves, JP Larsen, SG Møller
Experimental gerontology 68, 33-38, 2015
1082015
Mouse ghrelin‐O‐acyltransferase (GOAT) plays a critical role in bile acid reabsorption
K Kang, J Schmahl, JM Lee, K Garcia, K Patil, A Chen, M Keene, ...
The FASEB Journal 26 (1), 259-271, 2012
382012
Combinatory microRNA serum signatures as classifiers of Parkinson's disease
KS Patil, I Basak, I Dalen, E Hoedt, J Lange, KA Lunde, Y Liu, OB Tysnes, ...
Parkinsonism & Related Disorders 64, 202-210, 2019
352019
A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells
SGM Ketan S. Patil , Indranil Basak , Ramavati Pal, Hsin-Pin Ho, Guido Alves ...
PLoS ONE 10 (12), 2015
312015
Arabidopsis AtPARK13, which confers thermotolerance, targets misfolded proteins
I Basak, R Pal, KS Patil, A Dunne, HP Ho, S Lee, D Peiris, ...
Journal of Biological Chemistry 289 (21), 14458-14469, 2014
232014
PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons
KS Patil, I Basak, S Lee, R Abdullah, JP Larsen, SG Møller
Journal of Neuroscience Research 92 (9), 1167-1177, 2014
182014
t (14; 19)(q32; q13) incidence and significance in B‐cell lymphoproliferative disorders
RJ Kelly, D Wright, K Patil, M Chapple, SS Jalihal, SL Barrans, ...
British journal of haematology 141 (4), 561-563, 2008
122008
Subcellular Parkinson’s disease-specific alpha-synuclein species show altered behavior in neurodegeneration
R Abdullah, KS Patil, B Rosen, R Pal, S Prabhudesai, S Lee, I Basak, ...
Molecular neurobiology 54, 7639-7655, 2017
92017
Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential
TE Mullen, R Abdullah, J Boucher, AS Brousseau, NK Dasuri, NT Ditto, ...
Antibody Therapeutics 4 (3), 185-196, 2021
82021
A novel paper‐based microfluidic device and UV‐visible spectroscopy coupled method for the field detection and analysis of seized marijuana samples
R Krishna, K Patil, A Dixit, J Joseph, A Pandey
Applied Research 2 (4), e202200068, 2023
32023
Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform
MB Shapiro, J Boucher, A Brousseau, A Dehkharghani, J Gabriel, ...
Antibody Therapeutics 6 (3), 211-223, 2023
12023
Circulating serum microRNA biomarkers and methods for Alzheimer's disease diagnosis
SG Moller, KS Patil, GW Alves
US Patent 11,634,775, 2023
12023
Biomarker and target discovery in Parkinson's disease
KS Patil
St. John's University (New York), 2016
12016
The Serine Protease PARK13 Degrading Misfolded Parkinson's Disease Proteins And Confers Cellular Protection
I Basak, K Patil, JP Larsen, S Møller
The FASEB Journal 29, 894.6, 2015
12015
Circulating serum microrna biomarkers and methods for parkinson's disease prognosis
SG Moller, I Basak, K Patil, JP Larsen, GW Alves
US Patent App. 18/452,778, 2024
2024
Circulating serum cell-free dna biomarkers and methods
SG Møller, K Patil
US Patent App. 18/450,103, 2023
2023
Circulating serum microrna biomarkers and methods
SG Moller, I Basak, K Patil, JP Larsen
US Patent App. 18/045,065, 2023
2023
Circulating serum cell-free DNA biomarkers and methods
SG Møller, K Patil
US Patent 11,767,562, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20